State Street’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $137K | Sell |
85,452
-202,808
| -70% | -$324K | ﹤0.01% | 3917 |
|
|
2025
Q1 | $352K | Buy |
288,260
+39,664
| +16% | +$48.4K | ﹤0.01% | 3685 |
|
|
2024
Q4 | $470K | Buy |
248,596
+16,054
| +7% | +$30.3K | ﹤0.01% | 3636 |
|
|
2024
Q3 | $1.24M | Buy |
232,542
+21,201
| +10% | +$113K | ﹤0.01% | 3446 |
|
|
2024
Q2 | $1.56M | Buy |
211,341
+61,225
| +41% | +$452K | ﹤0.01% | 3393 |
|
|
2024
Q1 | $1.79M | Buy |
150,116
+8,791
| +6% | +$105K | ﹤0.01% | 3311 |
|
|
2023
Q4 | $1.11M | Buy |
141,325
+1,836
| +1% | +$14.5K | ﹤0.01% | 3465 |
|
|
2023
Q3 | $617K | Buy |
139,489
+1,890
| +1% | +$8.35K | ﹤0.01% | 3623 |
|
|
2023
Q2 | $4.79M | Buy |
137,599
+36,596
| +36% | +$1.27M | ﹤0.01% | 3015 |
|
|
2023
Q1 | $2.2M | Buy |
101,003
+5,019
| +5% | +$109K | ﹤0.01% | 3308 |
|
|
2022
Q4 | $2.07M | Sell |
95,984
-1,469
| -2% | -$31.7K | ﹤0.01% | 3364 |
|
|
2022
Q3 | $2.38M | Buy |
97,453
+2,986
| +3% | +$72.9K | ﹤0.01% | 3365 |
|
|
2022
Q2 | $1.93M | Buy |
94,467
+11,114
| +13% | +$227K | ﹤0.01% | 3491 |
|
|
2022
Q1 | $2.97M | Buy |
83,353
+4,965
| +6% | +$177K | ﹤0.01% | 3418 |
|
|
2021
Q4 | $2.13M | Buy |
78,388
+154
| +0.2% | +$4.19K | ﹤0.01% | 3613 |
|
|
2021
Q3 | $3.4M | Buy |
78,234
+11,108
| +17% | +$482K | ﹤0.01% | 3431 |
|
|
2021
Q2 | $3.34M | Buy |
+67,126
| New | +$3.34M | ﹤0.01% | 3418 |
|